What We Do

As far as I am aware, everyone who has tried this strategy has succeeded in eventually producing an interesting new drug.

Sir James Whyte Black (1924-2010)

---

Arzna Labs is a preclinical stage drug development company focuses on stroke treatment with small molecular compounds.

Our research paradigm: Disease-focused & polypharmacology-based drug discovery

Our research approach: Systems-based drug discovery (chemocentric approaches & phenotypic screening)

Our research strategy: Brain protection with magic shotguns (selectively non-selective drugs)